Overview
Provider of precision diagnosis and treatment services using ultrasound brain-computer interfaces.
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record.
No chartable funding estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jun 10, 2026 | Undisclosed · Series A | 武汉武创星火种苗创业投资基金合伙企业（有限合伙）, 湖北省楚天凤鸣科创天使投资基金合伙企业（有限合伙）, 珠海横琴金庄创业投资基金（有限合伙）, 珠海横琴铂华医学检验有限公司, 草本金方健康科技（广东）有限公司 | No source link |
Evidence Baiyingnuo raises an undisclosed amount in Series A financingOn 2026-06-10, according to Xiniu Data, Baiyingnuo completed Series A financing for an undisclosed amount. Investors were lead investor Hubei Shengchutianfengmingkechuangtianshi Investment Fund Partnership (Limited Partnership), participating investor Wuhan Wuchuangxinghuozhongmiao Venture Capital Fund Partnership (Limited Partnership), participating investor Caobenjinfangjiankang Technology (Guangdong) Co., Ltd., participating investor Zhuhai Hengqinbohuayixuejianyan Co., Ltd., participating investor Zhuhai Hengqinjinzhuang Venture Capital Fund (Limited Partnership). The company is a provider of precision diagnosis and treatment services using ultrasound brain-computer interfaces. Translated source brief, not a quotation. Check the original before citing. Sources · 0
武汉武创星火种苗创业投资基金合伙企业（有限合伙）, 湖北省楚天凤鸣科创天使投资基金合伙企业（有限合伙）, 珠海横琴金庄创业投资基金（有限合伙）, 珠海横琴铂华医学检验有限公司, 草本金方健康科技（广东）有限公司 | |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jun 10, 2026 | — · Series A | 武汉武创星火种苗创业投资基金合伙企业（有限合伙）, 湖北省楚天凤鸣科创天使投资基金合伙企业（有限合伙）, 珠海横琴金庄创业投资基金（有限合伙）, 珠海横琴铂华医学检验有限公司, 草本金方健康科技（广东）有限公司 | No source link |
Evidence Baiyingnuo raises an undisclosed amount in Series A financingOn 2026-06-10, according to Xiniu Data, Baiyingnuo completed Series A financing for an undisclosed amount. Investors were lead investor Hubei Shengchutianfengmingkechuangtianshi Investment Fund Partnership (Limited Partnership), participating investor Wuhan Wuchuangxinghuozhongmiao Venture Capital Fund Partnership (Limited Partnership), participating investor Caobenjinfangjiankang Technology (Guangdong) Co., Ltd., participating investor Zhuhai Hengqinbohuayixuejianyan Co., Ltd., participating investor Zhuhai Hengqinjinzhuang Venture Capital Fund (Limited Partnership). The company is a provider of precision diagnosis and treatment services using ultrasound brain-computer interfaces. Translated source brief, not a quotation. Check the original before citing. Sources · 0
武汉武创星火种苗创业投资基金合伙企业（有限合伙）, 湖北省楚天凤鸣科创天使投资基金合伙企业（有限合伙）, 珠海横琴金庄创业投资基金（有限合伙）, 珠海横琴铂华医学检验有限公司, 草本金方健康科技（广东）有限公司 | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
超声脑机接口精准诊疗服务提供商